Sfoglia per Rivista BRITISH JOURNAL OF CANCER
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
2015 Bazzola, Letizia; Foroni, Chiara; Andreis, Daniele; Zanoni, Vanessa; R. Cappelletti, Mariarosa Rosa; Allevi, Giovanni; Aguggini, Sergio; Strina, Carla; Milani, Manuela; Venturini, Sergio; Ferrozzi, Francesco; Giardini, Roberto; Bertoni, Ramona; Turley, Helen; Gatter, Kevin C; Petronini, Piergiorgio; Fox, Stephen B; Harris, Adrian L.; Martinotti, Mario; Berruti, Alfredo; Bottini, Alberto; Reynolds, Andrew R.; Generali, Daniele
COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment
2014 Generali, D.; Buffa, F. M.; Deb, S.; Cummings, M.; Reid, L. E.; Taylor, M.; Andreis, D.; Allevi, G.; Ferrero, G.; Byrne, D.; Martinotti, M.; Bottini, A.; Harris, A. L.; Lakhani, S. R.; Fox, S. B.
Duration of adjuvant chemotherapy for breast cancer: A joint analysis of two randomised trials investigating three versus six courses of CMF
2002 Colleoni, M.; Litman, H. J.; Castiglione-Gertsch, M.; Sauerbrei, W.; Gelber, R. D.; Bonetti, M.; Coates, A. S.; Schumacher, M.; Bastert, G.; Rudenstam, C. -M.; Schmoor, C.; Lindtner, J.; Collins, J.; Thurlimann, B.; Holmberg, S. B.; Crivellari, D.; Beyerle, C.; Neumann, R. L. A.; Goldhirsch, A.
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: A phase I study in progressive hormone refractory prostate cancer metastatic to bone
2002 O'Sullivan, J. M.; Mccready, V. R.; Flux, G.; Norman, A. R.; Buffa, F. M.; Chittenden, S.; Guy, M.; Pomeroy, K.; Cook, G.; Gadd, J.; Treleaven, J.; Al-Deen, A.; Horwich, A.; Huddart, R. A.; Dearnaley, D. P.
Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer
2013 Blick, C.; Ramachandran, A.; Wigfield, S.; Mccormick, R.; Jubb, A.; Buffa, F. M.; Turley, H.; Knowles, M. A.; Cranston, D.; Catto, J.; Harris, A. L.
IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer
2017 Aleksic, T.; Verrill, C.; Bryant, R. J.; Han, C.; Worrall, A. R.; Brureau, L.; Larre, S.; Higgins, G. S.; Fazal, F.; Sabbagh, A.; Haider, S.; Buffa, F. M.; Cole, D.; Macaulay, V. M.
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
2010 Buffa, F. M.; Harris, A. L.; West, C. M.; Miller, C. J.
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types
2008 Starmans, M. H. W.; Krishnapuram, B.; Steck, H.; Horlings, H.; Nuyten, D. S. A.; Van De Vijver, M. J.; Seigneuric, R.; Buffa, F. M.; Harris, A. L.; Wouters, B. G.; Lambin, P.
Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression
2014 Airley, R. E.; Mchugh, P.; Evans, A. R.; Harris, B.; Winchester, L.; Buffa, F. M.; Al-Tameemi, W.; Leek, R.; Harris, A. L.
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
2011 Gee, H. E.; Buffa, F. M.; Camps, C.; Ramachandran, A.; Leek, R.; Taylor, M.; Patil, M.; Sheldon, H.; Betts, G.; Homer, J.; West, C.; Ragoussis, J.; Harris, A. L.
TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
2017 Pirovano, G.; Ashton, T. M.; Herbert, K. J.; Bryant, R. J.; Verrill, C. L.; Cerundolo, L.; Buffa, F. M.; Prevo, R.; Harrap, I.; Ryan, A. J.; Macaulay, V.; Mckenna, W. G.; Higgins, G. S.
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin
2020 Lord, Simon R.; Collins, Jennifer M.; Cheng, Wei-Chen; Haider, Syed; Wigfield, Simon; Gaude, Edoardo; Fielding, Barbara A.; Pinnick, Katherine E.; Harjes, Ulrike; Segaran, Ashvina; Jha, Pooja; Hoefler, Gerald; Pollak, Michael N.; Thompson, Alastair M.; Roy, Pankaj G.; English, Ruth.; Adams, Rosie F.; Frezza, Christian; Buffa, Francesca M.; Karpe, Fredrik; Harris, Adrian L.
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer | 1-gen-2015 | Bazzola, Letizia; Foroni, Chiara; Andreis, Daniele; Zanoni, Vanessa; R. Cappelletti, Mariarosa Rosa; Allevi, Giovanni; Aguggini, Sergio; Strina, Carla; Milani, Manuela; Venturini, Sergio; Ferrozzi, Francesco; Giardini, Roberto; Bertoni, Ramona; Turley, Helen; Gatter, Kevin C; Petronini, Piergiorgio; Fox, Stephen B; Harris, Adrian L.; Martinotti, Mario; Berruti, Alfredo; Bottini, Alberto; Reynolds, Andrew R.; Generali, Daniele | BRITISH JOURNAL OF CANCER | - |
| COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment | 1-gen-2014 | Generali, D.; Buffa, F. M.; Deb, S.; Cummings, M.; Reid, L. E.; Taylor, M.; Andreis, D.; Allevi, G.; Ferrero, G.; Byrne, D.; Martinotti, M.; Bottini, A.; Harris, A. L.; Lakhani, S. R.; Fox, S. B. | BRITISH JOURNAL OF CANCER | - |
| Duration of adjuvant chemotherapy for breast cancer: A joint analysis of two randomised trials investigating three versus six courses of CMF | 1-gen-2002 | Colleoni, M.; Litman, H. J.; Castiglione-Gertsch, M.; Sauerbrei, W.; Gelber, R. D.; Bonetti, M.; Coates, A. S.; Schumacher, M.; Bastert, G.; Rudenstam, C. -M.; Schmoor, C.; Lindtner, J.; Collins, J.; Thurlimann, B.; Holmberg, S. B.; Crivellari, D.; Beyerle, C.; Neumann, R. L. A.; Goldhirsch, A. | BRITISH JOURNAL OF CANCER | Editore attuale:NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW Harcourt Publishers Limited:Foots Cray High Street, Sidcup Kent DA14 5HP United Kingdom:011 44 20 83085700, EMAIL: journals@harcourt.com, INTERNET: http://www.harcourt-international.com, Fax: 011 44 20 83085876 |
| High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: A phase I study in progressive hormone refractory prostate cancer metastatic to bone | 1-gen-2002 | O'Sullivan, J. M.; Mccready, V. R.; Flux, G.; Norman, A. R.; Buffa, F. M.; Chittenden, S.; Guy, M.; Pomeroy, K.; Cook, G.; Gadd, J.; Treleaven, J.; Al-Deen, A.; Horwich, A.; Huddart, R. A.; Dearnaley, D. P. | BRITISH JOURNAL OF CANCER | - |
| Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer | 1-gen-2013 | Blick, C.; Ramachandran, A.; Wigfield, S.; Mccormick, R.; Jubb, A.; Buffa, F. M.; Turley, H.; Knowles, M. A.; Cranston, D.; Catto, J.; Harris, A. L. | BRITISH JOURNAL OF CANCER | - |
| IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer | 1-gen-2017 | Aleksic, T.; Verrill, C.; Bryant, R. J.; Han, C.; Worrall, A. R.; Brureau, L.; Larre, S.; Higgins, G. S.; Fazal, F.; Sabbagh, A.; Haider, S.; Buffa, F. M.; Cole, D.; Macaulay, V. M. | BRITISH JOURNAL OF CANCER | - |
| Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene | 1-gen-2010 | Buffa, F. M.; Harris, A. L.; West, C. M.; Miller, C. J. | BRITISH JOURNAL OF CANCER | - |
| Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types | 1-gen-2008 | Starmans, M. H. W.; Krishnapuram, B.; Steck, H.; Horlings, H.; Nuyten, D. S. A.; Van De Vijver, M. J.; Seigneuric, R.; Buffa, F. M.; Harris, A. L.; Wouters, B. G.; Lambin, P. | BRITISH JOURNAL OF CANCER | - |
| Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression | 1-gen-2014 | Airley, R. E.; Mchugh, P.; Evans, A. R.; Harris, B.; Winchester, L.; Buffa, F. M.; Al-Tameemi, W.; Leek, R.; Harris, A. L. | BRITISH JOURNAL OF CANCER | - |
| The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis | 1-gen-2011 | Gee, H. E.; Buffa, F. M.; Camps, C.; Ramachandran, A.; Leek, R.; Taylor, M.; Patil, M.; Sheldon, H.; Betts, G.; Homer, J.; West, C.; Ragoussis, J.; Harris, A. L. | BRITISH JOURNAL OF CANCER | - |
| TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy | 1-gen-2017 | Pirovano, G.; Ashton, T. M.; Herbert, K. J.; Bryant, R. J.; Verrill, C. L.; Cerundolo, L.; Buffa, F. M.; Prevo, R.; Harrap, I.; Ryan, A. J.; Macaulay, V.; Mckenna, W. G.; Higgins, G. S. | BRITISH JOURNAL OF CANCER | - |
| Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin | 1-gen-2020 | Lord, Simon R.; Collins, Jennifer M.; Cheng, Wei-Chen; Haider, Syed; Wigfield, Simon; Gaude, Edoardo; Fielding, Barbara A.; Pinnick, Katherine E.; Harjes, Ulrike; Segaran, Ashvina; Jha, Pooja; Hoefler, Gerald; Pollak, Michael N.; Thompson, Alastair M.; Roy, Pankaj G.; English, Ruth.; Adams, Rosie F.; Frezza, Christian; Buffa, Francesca M.; Karpe, Fredrik; Harris, Adrian L. | BRITISH JOURNAL OF CANCER | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile